Rx ton of OTC SWITCHes - possibilities and requirements when dismissal from using up obligation

(openPR) - patients are taken in Germany ever more into the sole responsibility of health preservation and treatment in the medical case. For the pharmaceutical industry so the OTC market becomes ever more interesting. A SWITCH from the using up obligation is quite meaningful therefore depending upon area of application and active substance. For such medicaments the self medication market and thus completely new possibilities of the advertisement and marketing open.

FORUM Institut for management, one of the prominent seminar offerers of Germany, offers a compact advanced training to interested coworkers of pharmaceutical enterprises for this topic.
The intensive seminar takes place to 09.05.2007 in Bonn. Further information to the seminar and to the organizer finds you under: www.forum-institut.de/veranstaltung.aspSemNr=0705204

Pro and cons of a SWITCH of Rx ton of OTC are exactly the same brought up for discussion like its practical execution. Experience in addition all over the “SWITCH Guideline” in the detail and hear you legal experiences from practice.

Contact:
Dr. C. Michaela God forest
Range chief Pharma
FORUM Institut for management GmbH
Vangerowstrasse 18
69115 Heidelberg
Tel. 06221 500,610
Fax. 06221 500,618
m.gottwald@forum-institut.de

The FORUM Institut for management GmbH stands for 25 years for practice-oriented and founded knowledge transfer in enterprise questions on highest level. FORUM is 100% daughter of Springer Science + Business Media, one the offerer for science and technical literature, leading world-wide. The broadly varied offer covers conferences and conferences to current developments, in addition, seminars and training courses of several days. In the year 2005 more than 30,000 high-level personnel from almost all countries of Europe and from the United States participated on over 1.400 meetings of the institutes for forum.

Dieser Artikel wurde veröffentlicht auf
OpenPR - http://openpr.de/news/121121/Rx-to-OTC-Switch-Moeglichkeiten-und-Anforderungen-bei-Entlassung-aus-Verschreibungspflicht.html